These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 2087001)
21. Different metabolism of norepinephrine and epinephrine by catechol-O-methyltransferase and monoamine oxidase in rats. Eisenhofer G; Finberg JP J Pharmacol Exp Ther; 1994 Mar; 268(3):1242-51. PubMed ID: 8138937 [TBL] [Abstract][Full Text] [Related]
22. Monoamines (serotonin and catecholamines) and their derivatives in infantile autism: age-related changes and drug effects. Martineau J; Barthélémy C; Jouve J; Muh JP; Lelord G Dev Med Child Neurol; 1992 Jul; 34(7):593-603. PubMed ID: 1380929 [TBL] [Abstract][Full Text] [Related]
23. Type A monoamine oxidase catalyzes the intraneuronal deamination of dopamine within nigrostriatal, mesolimbic, tuberoinfundibular and tuberohypophyseal neurons in the rat. Demarest KT; Moore KE J Neural Transm; 1981; 52(3):175-87. PubMed ID: 6796650 [TBL] [Abstract][Full Text] [Related]
24. Effects of befloxatone, a new potent reversible MAO-A inhibitor, on cortex and striatum monoamines in freely moving rats. Curet O; Damoiseau G; Labaune JP; Rovel V; Jarreau FX J Neural Transm Suppl; 1994; 41():349-55. PubMed ID: 7931249 [TBL] [Abstract][Full Text] [Related]
25. Chronic cocaine and rat brain catecholamines: long-term reduction in hypothalamic and frontal cortex dopamine metabolism. Karoum F; Suddath RL; Wyatt RJ Eur J Pharmacol; 1990 Sep; 186(1):1-8. PubMed ID: 2282931 [TBL] [Abstract][Full Text] [Related]
26. Postnatal development of dopamine deamination in the striatum of the rat. Davis AJ; Holzbauer M; Sharman DF Br J Pharmacol; 1975 Dec; 55(4):558-60. PubMed ID: 1212563 [TBL] [Abstract][Full Text] [Related]
27. SL25.1131 [3(S),3a(S)-3-methoxymethyl-7-[4,4,4-trifluorobutoxy]-3,3a,4,5-tetrahydro-1,3-oxazolo[3,4-a]quinolin-1-one], a new, reversible, and mixed inhibitor of monoamine oxidase-A and monoamine oxidase-B: biochemical and behavioral profile. Aubin N; Barneoud P; Carter C; Caille D; Sontag N; Marc C; Lolivier J; Gardes A; Perron C; Le Kim A; Charieras T; Pandini M; Burnier P; Puech F; Jegham S; George P; Scatton B; Curet O J Pharmacol Exp Ther; 2004 Sep; 310(3):1171-82. PubMed ID: 15178694 [TBL] [Abstract][Full Text] [Related]
28. Monoamine oxidase-dependent metabolism of dopamine in the striatum and substantia nigra of L-DOPA-treated monkeys. Di Monte DA; DeLanney LE; Irwin I; Royland JE; Chan P; Jakowec MW; Langston JW Brain Res; 1996 Oct; 738(1):53-9. PubMed ID: 8949927 [TBL] [Abstract][Full Text] [Related]
29. Increased dopaminergic and 5-hydroxytryptaminergic activities in male rat brain following long-term treatment with anabolic androgenic steroids. Thiblin I; Finn A; Ross SB; Stenfors C Br J Pharmacol; 1999 Mar; 126(6):1301-6. PubMed ID: 10217522 [TBL] [Abstract][Full Text] [Related]
30. Effects of acute and repeated administration of amiflamine on monoamine oxidase inhibition in the rat. Ask AL; Fagervall I; Jonze M; Kelder D; Nygren R; Ross SB Biochem Pharmacol; 1984 Sep; 33(18):2839-47. PubMed ID: 6477643 [TBL] [Abstract][Full Text] [Related]
31. Acute effects of lithium on catecholamines, serotonin, and their major metabolites in discrete brain regions. Gottberg E; Grondin L; Reader TA J Neurosci Res; 1989 Mar; 22(3):338-45. PubMed ID: 2709448 [TBL] [Abstract][Full Text] [Related]
33. Effects of transient global ischemia and a monoamine oxidase inhibitor ifenprodil on rat brain monoamine metabolism. Tadano T; Yonezawa A; Oyama K; Kisara K; Arai Y; Togashi M; Kinemuchi H Prog Brain Res; 1995; 106():173-80. PubMed ID: 8584652 [TBL] [Abstract][Full Text] [Related]
34. Effects of ketamine on dopamine metabolism during anesthesia in discrete brain regions in mice: comparison with the effects during the recovery and subanesthetic phases. Irifune M; Fukuda T; Nomoto M; Sato T; Kamata Y; Nishikawa T; Mietani W; Yokoyama K; Sugiyama K; Kawahara M Brain Res; 1997 Jul; 763(2):281-4. PubMed ID: 9296573 [TBL] [Abstract][Full Text] [Related]
35. Influence of neonatal and adult hyperthyroidism on behavior and biosynthetic capacity for norepinephrine, dopamine and 5-hydroxytryptamine in rat brain. Rastogi RB; Singhal RL J Pharmacol Exp Ther; 1976 Sep; 198(3):609-18. PubMed ID: 978462 [TBL] [Abstract][Full Text] [Related]
36. Determination of monoamines and both forms of monoamine oxidase in the rat's substantia nigra during postnatal development. Venero JL; Santiago M; Machado A; Cano J Life Sci; 1989; 45(14):1277-83. PubMed ID: 2811598 [TBL] [Abstract][Full Text] [Related]
37. Changes in dopamine, serotonin and their metabolites in discrete brain areas of rat offspring after in utero exposure to cocaine or related drugs. Henderson MG; McMillen BA Teratology; 1993 Nov; 48(5):421-30. PubMed ID: 7508151 [TBL] [Abstract][Full Text] [Related]
38. Short-term atrazine exposure causes behavioral deficits and disrupts monoaminergic systems in male C57BL/6 mice. Lin Z; Dodd CA; Filipov NM Neurotoxicol Teratol; 2013; 39():26-35. PubMed ID: 23770127 [TBL] [Abstract][Full Text] [Related]
39. Acute pancreatitis affects the metabolism of catecholamine neurotransmitters in rats. Jiang H; Li F; Liu S; Sun H; Cui Y; Wu Y Neuroscience; 2014 May; 268():112-7. PubMed ID: 24657461 [TBL] [Abstract][Full Text] [Related]
40. Specificity of endogenous substrates for types A and B monoamine oxidase in rat striatum. Schoepp DD; Azzaro AJ J Neurochem; 1981 Jun; 36(6):2025-31. PubMed ID: 6787175 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]